| Bioactivity | Etavopivat is a potent, selective, orally bioavailable red blood cell (RBC) pyruvate kinase (PKR) activator. Etavopivat has potent antisickling effects[1]. | ||||||||||||
| Name | Etavopivat | ||||||||||||
| CAS | 2245053-57-8 | ||||||||||||
| Formula | C22H23N3O6S | ||||||||||||
| Molar Mass | 457.50 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Shrestha A, et al. FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice. Blood Adv. 2021 May 11;5(9):2385-2390. |
Etavopivat
CAS: 2245053-57-8 F: C22H23N3O6S W: 457.50
Etavopivat is a potent, selective, orally bioavailable red blood cell (RBC) pyruvate kinase (PKR) activator. Etavopivat
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.